FDA Approval of Over-the-Counter Emergency Contraception Has Slashed ER Visits
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
TUESDAY, Jan. 30, 2024 -- U.S. approval of over-the-counter emergency contraception like “Plan B” has had an unintended but positive side effect for America’s hospitals, a new study shows.
Emergency room visits related to “morning-after” contraception plummeted after the pills became easily available to adults in 2006, according to the report published Jan. 24 in the journal JAMA Network Open.
ERs saw 96% fewer visits from women seeking emergency contraception, falling from 17,019 to 659 between 2006 and 2020, researchers found.
That saved $7.2 million in hospital expenses, researchers estimated -- a drop from $7.6 million in 2006 to just under $386,000 in 2020.
“Emergency departments are important sites for accessing emergency contraception given their 24-hour access and high acuity care,” said senior researcher Dr. Erica Marsh, chief of reproductive endocrinology and infertility at the University of Michigan Health Von Voigtlander Women's Hospital.
For the study, researchers analyzed national data of more than 2 million ER visits among women ages 15 to 44 during the 14-year period.
The U.S. Food and Drug Administration approved the first product for emergency contraception in 1998, with over-the-counter approval following for adults in 2006 and minors in 2013. Coverage by insurance is mandated by the Affordable Care Act.
Women who go to the ER for emergency contraception tend to be younger, low-income, Medicaid-insured and Black or Hispanic, researchers discovered.
“We found an overrepresentation of certain demographic groups utilizing emergency departments for emergency contraception,” Marsh said in a university news release. “This aligns with previous outpatient research suggesting ongoing barriers to over-the-counter emergency contraception access and or increased emergency department utilization for other reasons, including sexual assault.”
Northeast hospitals saw the most visits for emergency contraception, accounting for 44% to 59% of the national total despite having just 17% to 19% of overall ER visits.
Meanwhile, southern hospitals saw just 4.5% to 17% of visits related to emergency contraception, despite consistently averaging more than 40% of other types of ER visits, researchers found.
“Our analysis suggests ongoing barriers in over-the-counter emergency contraception and disparities in utilization for certain populations,” Marsh said. “Future policies should reduce barriers to make emergency contraception safe and affordable to all.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-30 22:15
Read more
- Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
- FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
- Using Abortion Pills Very Early in Pregnancy Is Safe, Study Finds
- People's Brains Now Process Texts Almost as Quickly as Pictures
- Patient-Reported Lumbar Symptom Information Beneficial for Radiologists
- Bystanders More Readily Perform CPR If 911 Operator Instructs
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions